To Top

April 4, 2022

TOPIC: Patients & Members, Rare Disease Day

Rare Disease Day and the Spotlight on NORD Member Organizations

Posted by Rohan Narayanan

Rare Disease Day Recap

Rare Disease Day took place on February, 28, 2022 and successfully raised awareness for the 7,000+ rare diseases that impact over 300 million people globally. NORD is proud to partner with EURORDIS (Rare Diseases – Europe) and others all around the world to drive an international campaign that shines a light on rare diseases… Read More

March 30, 2022


From Pain To Purpose: Kari Luther Rosbeck

Posted by Valaree DonFrancesco

Kari Luther Rosbeck is the President & Chief Executive Officer of the TSC Alliance, a nonprofit whose mission is to find a cure for Tuberous Sclerosis Complex (TSC) while improving the lives of those affected. Kari began her life as a Theater nerd and started her… Read More

March 16, 2022


Chris Anselmo: The Accidental Muscular Dystrophy Advocate

Posted by Valaree DonFrancesco

Chris Anselmo is the Director of Market Intelligence at the Muscular Dystrophy Association but he never envisioned becoming an advocate for a disease he never thought he’d get. After a car crash found him in the hospital on the receiving end of a random diagnosis of having extremely high creatine kinase levels, he was soon… Read More

March 15, 2022

TOPIC: Press Releases

Honoring the Rock Stars of the Rare Disease Community: NORD Announces the 2022 Rare Impact Award Honorees

Posted by Rohan Narayanan

NORD’s Rare Impact Award ceremony on June 26 will honor all those making strides to improve the lives of patients and families in the rare disease community 

Cleveland, OH, March 15, 2022—Today, the National Organization for Rare Disorders (NORD®) announced the 2022 Rare Impact Award honorees. This list of outstanding individuals, organizations and industry innovators will… Read More

March 11, 2022

TOPIC: Advocacy

FDA’s Accelerated Approval Pathway: A Rare Disease Perspective

Posted by Valaree DonFrancesco

Accelerated approval is critical to providing access to new, safe, and effective drugs to patients with serious and life-threatening diseases and conditions for which there are no meaningful alternatives. Learn more about the history of accelerated approval, how its use has benefited rare disease patients, and recommendations for strengthening the accelerated approval pathway by clicking here.